Ye Y Z, Duan J, Hu Z Q, Cao D Z, Liao J X, Chen L
Department of Neurology, Shenzhen Children's Hospital, Shenzhen 518038, China.
Zhonghua Er Ke Za Zhi. 2022 Jun 2;60(6):583-587. doi: 10.3760/cma.j.cn112140-20211126-00994.
To summarize the clinical phenotype of patients with developmental and epileptic encephalopathy 85 caused by SMC1A gene truncating variation. The clinical data of 4 patients with epileptic encephalopathy caused by SMC1A gene truncating variation from August 2016 to June 2020 were analyzed retrospectively. Related literatures up to October 2021 with the key words "SMC1A" "Developmental and epileptic encephalopathy 85" "SMC1A, epilepsy" and "SMC1A, truncating" in PubMed, CNKI, and Wanfang databases were searched. Relevant literature was summarized and reviewed. These 4 patients were all female. The onset age of seizure were all in the infantile period. They were admitted to the hospital at 3, 2, 11 and 18 months respectively. Focal seizures occurred in all 4 patients, while 1 of them experienced infantile spasm. The characteristic of cluster was observed in all of them with an interval of 14 days to 5.0 months. The seizures were all refractory to different kinds of anti-seizure medications. All 4 patients had severe developmental retardation with microcephaly (head circumference<-2 ). The interictal electroencephalogram (EEG) was characterized by diffuse slow wave. The 4 SMC1A gene variants were p.Gly655fs, p.Glu811fs, p.Arg412fs and p.Ile143fs, all of which were frameshift variation after parental validation. There were another 17 cases with SMC1A gene truncating variation reported in 6 English articles and 1 Chinese article. Among these 21 patients, who were all female, the onset of seizures occurred between 0.5 and 18.0 months of age. Seventeen cases (81%) had the characteristics of cluster attacks, and the intervals of attack cycles were different. Seizure types included generalized tonic-clonic seizure (12 cases (57%)), focal seizure (11 cases(52%)), myoclonic(4 cases(19%)), spasm (4 cases(19%)), atypical absence (3 cases(14%)), tonic seizure (2 cases (10%)), and atonia (1 case(5%)). In addition, 4 cases (19%) had status epilepsy. All patients had moderate to severe mental retardation. Microcephaly was found in all patients. Among 18 cases,EEG in 8 cases had diffuse slow wave background. Brain magnetic resonance imaging (MRI) was normal in 13 cases (62%). Other MRI changes included cerebellar atrophy (3 cases), thin corpus callosum (3 cases), and lateral ventricular enlargement (2 cases). Twenty patients did not respond well to antiepileptic drugs. The clinical phenotypes of patients with epilepsy encephalopathy 85 caused by SMC1A gene truncating variation are characterized by female, early-onset, clustering of seizures, development delay and microcephaly. Diffuse slow waves are shown in interictal EEG in partial. Response to treatment and prognosis are poor.
总结由SMC1A基因截短变异导致的85型发育性和癫痫性脑病患者的临床表型。回顾性分析2016年8月至2020年6月期间4例由SMC1A基因截短变异引起的癫痫性脑病患者的临床资料。在PubMed、中国知网和万方数据库中检索截至2021年10月的相关文献,关键词为“SMC1A”“85型发育性和癫痫性脑病”“SMC1A,癫痫”和“SMC1A,截短”。对相关文献进行总结和综述。这4例患者均为女性。癫痫发作起病年龄均在婴儿期,分别于3个月、2个月、11个月和18个月入院。4例患者均有局灶性发作,其中1例有婴儿痉挛发作。均观察到成簇发作特点,发作间隔为14天至5.0个月。所有发作对不同种类的抗癫痫药物均耐药。4例患者均有严重发育迟缓并伴有小头畸形(头围<-2)。发作间期脑电图特征为弥漫性慢波。经父母验证,4个SMC1A基因变异分别为p.Gly655fs、p.Glu811fs、p.Arg412fs和p.Ile143fs,均为移码变异。6篇英文文章和1篇中文文章报道了另外17例SMC1A基因截短变异病例。这21例患者均为女性,癫痫发作起病年龄在0.5至18.0个月之间。17例(81%)有簇状发作特点,发作周期间隔不同。发作类型包括全身强直阵挛发作(12例(57%))、局灶性发作(11例(52%))、肌阵挛发作(4例(19%))、痉挛发作(4例(19%))、不典型失神发作(3例(14%))、强直发作(2例(10%))和失张力发作(1例(5%))。此外,4例(19%)有癫痫持续状态。所有患者均有中度至重度智力发育迟缓。所有患者均有小头畸形。18例患者中,8例脑电图有弥漫性慢波背景。13例(62%)脑磁共振成像(MRI)正常。其他MRI改变包括小脑萎缩(3例)、胼胝体变薄(3例)和侧脑室扩大(2例)。20例患者对抗癫痫药物反应不佳。由SMC1A基因截短变异导致的85型癫痫性脑病患者的临床表型特点为女性、起病早、发作成簇、发育延迟和小头畸形。部分患者发作间期脑电图显示弥漫性慢波。治疗反应和预后较差。